The Big Shorts: How Buy-Side Stock Holdings Disclosures Reveal Firms’ Short Sale Strategies

With short trading activity frequently accounting for more than 50 percent of a stock’s total traded volume, according to Finra, and some “spectacular” short trades recorded in the past year, short sales can be both profitable and risky. Max Bowie reports on startup Caretta Data’s efforts to bring transparency and insight to short trading.

Buy and sell

Founder and director Adam Longenecker—a quantitative research analyst whose work as director of quantitative research at fund flows data vendor EPFR Global  helped the vendor increase sales by more than 400 percent over four years—originally set up Caretta to analyze holdings in exchange-traded funds. “I had high-end quants wanting me to do what I’d done at EPFR for ETF data,” he says.

However, midway through compiling its ETF holdings dataset, Longenecker says the vendor “stumbled across” a

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Cutting through the hype surrounding the FDTA rulemaking process

A bill requiring US regulators and institutions to adopt a machine-readable data framework for reporting purposes applies to entity identifiers, but not security identifiers, in a crucial difference, writes Scott Preiss, SVP and global head of Cusip Global Services.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here